Literature DB >> 10343502

Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres.

H Sah1.   

Abstract

The objective of this study was to investigate the behavior of three proteins at an organic solvent/water interface. To simulate the first microencapsulation step of a water-in-oil-in-water emulsion technique, a water-in-oil emulsion was prepared by emulsifying an aqueous protein solution in either methylene chloride or ethyl acetate. Phase separation was then followed to collect protein samples from the aqueous phase and the organic solvent/water interface. Their properties were assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and size exclusion-HPLC. Bovine serum albumin was relatively unharmed during emulsification, compared to other proteins such as ovalbumin and lysozyme. In particular, the methylene chloride treatment on ovalbumin led to the formation of a large quantity of water-insoluble, solid-like aggregates and changes in the composition of monomeric and dimeric ovalbumin species. With regard to the question of ovalbumin recovery, only 9.74 approximately 37.72% of the used ovalbumin was present in the aqueous phases after emulsification. Similar penchant was noted with lysozyme. Water-insoluble aggregates brought with by emulsification were found to be covalently bound. Interestingly, less emulsification-induced denaturing effects were observed with ethyl acetate. Our study clearly demonstrated the emulsification-induced adverse events that were detrimental to the integrity of proteins and the importance of preserving protein stability toward microencapsulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10343502

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  17 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone.

Authors:  Yilmaz Capan; Ge Jiang; Stefano Giovagnoli; Kyu-Heum Na; Patrick P DeLuca
Journal:  AAPS PharmSciTech       Date:  2003       Impact factor: 3.246

3.  Solvent exchange method: a novel microencapsulation technique using dual microdispensers.

Authors:  Yoon Yeo; Alvin U Chen; Osman A Basaran; Kinam Park
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

4.  Characterization of reservoir-type microcapsules made by the solvent exchange method.

Authors:  Yoon Yeo; Kinam Park
Journal:  AAPS PharmSciTech       Date:  2004-09-17       Impact factor: 3.246

5.  Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.

Authors:  B H Woo; G Jiang; Y W Jo; P P DeLuca
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

6.  Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Authors:  Enrica De Rosa; Ciro Chiappini; Dongmei Fan; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

7.  Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.

Authors:  Ajay Taluja; You Han Bae
Journal:  Mol Pharm       Date:  2007-04-18       Impact factor: 4.939

8.  Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.

Authors:  Ge Jiang; Wei Qiu; Patrick P DeLuca
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

9.  Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.

Authors:  Senja K Lopac; Maria P Torres; Jennifer H Wilson-Welder; Michael J Wannemuehler; Balaji Narasimhan
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-11       Impact factor: 3.368

10.  Light-activated, in situ forming gel for sustained suprachoroidal delivery of bevacizumab.

Authors:  Puneet Tyagi; Matthew Barros; Jeffrey W Stansbury; Uday B Kompella
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.